Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Leukopenia

cetylpyridinium chloride anhydrous has been researched along with Leukopenia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bruserud, Ø; Ersvaer, E; Gjertsen, BT; Liseth, K; Skavland, J1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Leukopenia

ArticleYear
Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells.
    BMC immunology, 2010, Jul-09, Volume: 11

    Topics: Adult; Antineoplastic Agents; CD3 Complex; CD8-Positive T-Lymphocytes; Cell Movement; Female; Forkhead Transcription Factors; Health; Humans; Interleukin-2 Receptor alpha Subunit; Leukemia, Myeloid, Acute; Leukopenia; Male; Middle Aged; Sex Characteristics; T-Lymphocyte Subsets; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory; Tumor Cells, Cultured; Young Adult

2010